|
WO1993017682A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
|
GB9421816D0
(en)
|
1994-10-29 |
1994-12-14 |
Smithkline Beecham Plc |
Novel compounds
|
|
SK80397A3
(en)
|
1994-12-22 |
1998-01-14 |
Smithkline Beecham Plc |
Substituted azetidin-2-ones, preparation method thereof, farmaceutical compositions and their use
|
|
CH690264A5
(fr)
|
1995-06-30 |
2000-06-30 |
Symphar Sa |
Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
|
|
AU708032B2
(en)
|
1995-07-01 |
1999-07-29 |
Smithkline Beecham Plc |
Azetidinone derivatives for the treatment of atherosclerosis
|
|
WO1997012963A2
(en)
|
1995-09-29 |
1997-04-10 |
Smithkline Beecham Plc |
A paf-acetylhydrolase and use in therapy
|
|
EP0869943A1
(en)
|
1995-12-08 |
1998-10-14 |
Smithkline Beecham Plc |
Monocyclic beta-lactame derivatives for treatment of atherosclerosis
|
|
WO1997021676A1
(en)
|
1995-12-08 |
1997-06-19 |
Smithkline Beecham Plc |
Azetidinone compounds for the treatment of atherosclerosis
|
|
NZ332476A
(en)
|
1996-04-26 |
2000-06-23 |
Smithkline Beecham Plc |
substituted 4-(carboxybenzylsulphinyl)-2-oxo-azetidine derivatives
|
|
GB9608649D0
(en)
|
1996-04-26 |
1996-07-03 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9626536D0
(en)
|
1996-12-20 |
1997-02-05 |
Symphar Sa |
Novel compounds
|
|
GB9626616D0
(en)
|
1996-12-20 |
1997-02-05 |
Symphar Sa |
Novel compounds
|
|
GB9626615D0
(en)
|
1996-12-20 |
1997-02-05 |
Symphar Sa |
Novel compounds
|
|
CA2309177A1
(en)
|
1997-11-06 |
1999-05-20 |
Stephen Allan Smith |
Pyrimidinone compounds and pharmaceutical compositions containing them
|
|
US6559155B1
(en)
|
1998-08-21 |
2003-05-06 |
Smithkline Beecham P.L.C. |
Pyrimidinone derivatives for the treatment of atherosclerosis
|
|
BR0010220A
(pt)
|
1999-05-01 |
2002-05-14 |
Smithkline Beecham Plc |
Compostos de pirimidinona
|
|
GB9910079D0
(en)
|
1999-05-01 |
1999-06-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9910378D0
(en)
|
1999-05-05 |
1999-06-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP3757703B2
(ja)
|
1999-09-22 |
2006-03-22 |
凸版印刷株式会社 |
再封可能な開口維持部材付パウチ
|
|
SI1686119T1
(sl)
|
2000-02-16 |
2009-12-31 |
Smithkline Beecham Plc |
Derivati pirimidin-5-ona kot inhibitorji ldl-pla2
|
|
GB0024808D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0024807D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0119793D0
(en)
|
2001-08-14 |
2001-10-03 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0119795D0
(en)
|
2001-08-14 |
2001-10-03 |
Smithkline Beecham Plc |
Novel process
|
|
GB0127140D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Novel compounds
|
|
GB0127143D0
(en)
*
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Novel compounds
|
|
GB0127141D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0127139D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Novel compounds
|
|
GB0208280D0
(en)
|
2002-04-10 |
2002-05-22 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0208279D0
(en)
*
|
2002-04-10 |
2002-05-22 |
Glaxo Group Ltd |
Novel compounds
|
|
US20040077635A1
(en)
|
2002-10-02 |
2004-04-22 |
Qiao Jennifer X. |
Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor Xa inhibitors
|
|
CA2500952C
(en)
|
2002-10-04 |
2011-04-26 |
Prana Biotechnology Limited |
Neurologically-active compounds
|
|
WO2005003118A1
(de)
|
2003-07-02 |
2005-01-13 |
Bayer Healthcare Ag |
Amid-substituierte 1,2,4-triazin-5 (2h)-one zur behandlung von chronisch inflammatorischen krankheiten
|
|
DE102004061009A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
Substituierte 1,2,4-Triazin-5(2H)-one
|
|
DE102004061008A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one
|
|
US20080090852A1
(en)
|
2006-10-13 |
2008-04-17 |
Colin Andrew Leach |
Bicyclic Heteroaromatic Compounds
|
|
JP2010506852A
(ja)
*
|
2006-10-13 |
2010-03-04 |
グラクソ グループ リミテッド |
二環式ヘテロ芳香族化合物
|
|
US20080090851A1
(en)
|
2006-10-13 |
2008-04-17 |
Colin Andrew Leach |
Bicyclic Heteroaromatic Compounds
|
|
US7705005B2
(en)
|
2006-10-13 |
2010-04-27 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
|
MX2009012197A
(es)
|
2007-05-11 |
2010-01-15 |
Univ Pennsylvania |
Metodos para tratamiento de ulceras en la piel.
|
|
US20080279846A1
(en)
*
|
2007-05-11 |
2008-11-13 |
Thomas Jefferson University |
Methods of treatment and prevention of neurodegenerative diseases and disorders
|
|
US8962633B2
(en)
|
2007-05-11 |
2015-02-24 |
Thomas Jefferson University |
Methods of treatment and prevention of metabolic bone diseases and disorders
|
|
US20090246198A1
(en)
|
2008-03-31 |
2009-10-01 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
|
AU2010327936B2
(en)
|
2009-12-11 |
2015-08-20 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
JP5886310B2
(ja)
*
|
2010-12-06 |
2016-03-16 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｌｐ−ＰＬＡ２により媒介される疾患または状態の処置における使用のためのピリミジノン化合物
|
|
JP2013545792A
(ja)
|
2010-12-17 |
2013-12-26 |
グラクソ グループ リミテッド |
眼疾患の処置および防止方法
|
|
JP2014521625A
(ja)
*
|
2011-07-27 |
2014-08-28 |
グラクソ グループ リミテッド |
二環式ピリミドン化合物
|